APO RESEARCH · REPORT
AI-powered Coronary Artery Calcium (CAC) Analysis Software
Selected research
Industry Research
AI-powered Coronary Artery Calcium (CAC) Analysis Software Industry Research Report 2026
Market perspective
The global AI-powered Coronary Artery Calcium (CAC) Analysis Software market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the AI-powered Coronary Artery Calcium (CAC) Analysis Software market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the AI-powered Coronary Artery Calcium (CAC) Analysis Software market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the AI-powered Coronary Artery Calcium (CAC) Analysis Software market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of AI-powered Coronary Artery Calcium (CAC) Analysis Software include Aidoc, Cleerly, Nanox.AI, HeartFlow, Siemens Healthineers, Canon Medical Systems, RADLogics, GE HealthCare and Philips Healthcare, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global AI-powered Coronary Artery Calcium (CAC) Analysis Software market in terms of revenue (US$ million) and, where applicable, service volume (k units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/k units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to AI-powered Coronary Artery Calcium (CAC) Analysis Software.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
AI-powered Coronary Artery Calcium (CAC) Analysis Software Market by Company
Aidoc
Cleerly
Nanox.AI
HeartFlow
Siemens Healthineers
Canon Medical Systems
RADLogics
GE HealthCare
Philips Healthcare
Infervision
Deepwise
RSIP Vision
AI-powered Coronary Artery Calcium (CAC) Analysis Software Segment by Type
Dedicated Calcification Scoring Software
Enhanced CT Plaque Analysis Software
AI-powered Coronary Artery Calcium (CAC) Analysis Software Segment by Application
Clinical Diagnosis Treatment
Health Management
Scientific Research
Other
AI-powered Coronary Artery Calcium (CAC) Analysis Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AI-powered Coronary Artery Calcium (CAC) Analysis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of AI-powered Coronary Artery Calcium (CAC) Analysis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AI-powered Coronary Artery Calcium (CAC) Analysis Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of AI-powered Coronary Artery Calcium (CAC) Analysis Software companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Dedicated Calcification Scoring Software
- Enhanced CT Plaque Analysis Software
Applications
- Clinical Diagnosis Treatment
- Health Management
- Scientific Research
- Other
Companies covered
- Aidoc
- Cleerly
- Nanox.AI
- HeartFlow
- Siemens Healthineers
- Canon Medical Systems
- RADLogics
- GE HealthCare
- Philips Healthcare
- Infervision
- Deepwise
- RSIP Vision
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 AI-powered Coronary Artery Calcium (CAC) Analysis Software by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Dedicated Calcification Scoring Software
- 2.2.3 Enhanced CT Plaque Analysis Software
- 2.3 AI-powered Coronary Artery Calcium (CAC) Analysis Software by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Clinical Diagnosis Treatment
- 2.3.3 Health Management
- 2.3.4 Scientific Research
- 2.3.5 Other
- 2.4 Assumptions and Limitations
3 AI-powered Coronary Artery Calcium (CAC) Analysis Software Breakdown Data by Type
- 3.1 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Historic Market Size by Type (2021-2026)
- 3.2 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Forecasted Market Size by Type (2027-2032)
4 AI-powered Coronary Artery Calcium (CAC) Analysis Software Breakdown Data by Application
- 4.1 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Historic Market Size by Application (2021-2026)
- 4.2 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Perspective (2021-2032)
- 5.2 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Growth Trends by Region
- 5.2.1 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 AI-powered Coronary Artery Calcium (CAC) Analysis Software Historic Market Size by Region (2021-2026)
- 5.2.3 AI-powered Coronary Artery Calcium (CAC) Analysis Software Forecasted Market Size by Region (2027-2032)
- 5.3 AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Dynamics
- 5.3.1 AI-powered Coronary Artery Calcium (CAC) Analysis Software Industry Trends
- 5.3.2 AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Drivers
- 5.3.3 AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Challenges
- 5.3.4 AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top AI-powered Coronary Artery Calcium (CAC) Analysis Software Players by Revenue
- 6.1.1 Global Top AI-powered Coronary Artery Calcium (CAC) Analysis Software Players by Revenue (2021-2026)
- 6.1.2 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Revenue Market Share by Players (2021-2026)
- 6.2 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of AI-powered Coronary Artery Calcium (CAC) Analysis Software Head Office and Area Served
- 6.4 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Players, Product Type & Application
- 6.5 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Manufacturers Established Date
- 6.6 Global AI-powered Coronary Artery Calcium (CAC) Analysis Software Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size (2021-2032)
- 7.2 North America AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size by Country (2021-2026)
- 7.4 North America AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size (2021-2032)
- 8.2 Europe AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size by Country (2021-2026)
- 8.4 Europe AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size (2021-2032)
- 9.2 Asia-Pacific AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size by Country (2021-2026)
- 9.4 Asia-Pacific AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size (2021-2032)
- 10.2 South America AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size by Country (2021-2026)
- 10.4 South America AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size (2021-2032)
- 11.2 Middle East & Africa AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size by Country (2021-2026)
- 11.4 Middle East & Africa AI-powered Coronary Artery Calcium (CAC) Analysis Software Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Aidoc
- 12.1.1 Aidoc Company Information
- 12.1.2 Aidoc Business Overview
- 12.1.3 Aidoc Revenue in AI-powered Coronary Artery Calcium (CAC) Analysis Software Business (2021-2026)
- 12.1.4 Aidoc AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
- 12.1.5 Aidoc Recent Developments
- 12.2 Cleerly
- 12.2.1 Cleerly Company Information
- 12.2.2 Cleerly Business Overview
- 12.2.3 Cleerly Revenue in AI-powered Coronary Artery Calcium (CAC) Analysis Software Business (2021-2026)
- 12.2.4 Cleerly AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
- 12.2.5 Cleerly Recent Developments
- 12.3 Nanox.AI
- 12.3.1 Nanox.AI Company Information
- 12.3.2 Nanox.AI Business Overview
- 12.3.3 Nanox.AI Revenue in AI-powered Coronary Artery Calcium (CAC) Analysis Software Business (2021-2026)
- 12.3.4 Nanox.AI AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
- 12.3.5 Nanox.AI Recent Developments
- 12.4 HeartFlow
- 12.4.1 HeartFlow Company Information
- 12.4.2 HeartFlow Business Overview
- 12.4.3 HeartFlow Revenue in AI-powered Coronary Artery Calcium (CAC) Analysis Software Business (2021-2026)
- 12.4.4 HeartFlow AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
- 12.4.5 HeartFlow Recent Developments
- 12.5 Siemens Healthineers
- 12.5.1 Siemens Healthineers Company Information
- 12.5.2 Siemens Healthineers Business Overview
- 12.5.3 Siemens Healthineers Revenue in AI-powered Coronary Artery Calcium (CAC) Analysis Software Business (2021-2026)
- 12.5.4 Siemens Healthineers AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
- 12.5.5 Siemens Healthineers Recent Developments
- 12.6 Canon Medical Systems
- 12.6.1 Canon Medical Systems Company Information
- 12.6.2 Canon Medical Systems Business Overview
- 12.6.3 Canon Medical Systems Revenue in AI-powered Coronary Artery Calcium (CAC) Analysis Software Business (2021-2026)
- 12.6.4 Canon Medical Systems AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
- 12.6.5 Canon Medical Systems Recent Developments
- 12.7 RADLogics
- 12.7.1 RADLogics Company Information
- 12.7.2 RADLogics Business Overview
- 12.7.3 RADLogics Revenue in AI-powered Coronary Artery Calcium (CAC) Analysis Software Business (2021-2026)
- 12.7.4 RADLogics AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
- 12.7.5 RADLogics Recent Developments
- 12.8 GE HealthCare
- 12.8.1 GE HealthCare Company Information
- 12.8.2 GE HealthCare Business Overview
- 12.8.3 GE HealthCare Revenue in AI-powered Coronary Artery Calcium (CAC) Analysis Software Business (2021-2026)
- 12.8.4 GE HealthCare AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
- 12.8.5 GE HealthCare Recent Developments
- 12.9 Philips Healthcare
- 12.9.1 Philips Healthcare Company Information
- 12.9.2 Philips Healthcare Business Overview
- 12.9.3 Philips Healthcare Revenue in AI-powered Coronary Artery Calcium (CAC) Analysis Software Business (2021-2026)
- 12.9.4 Philips Healthcare AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
- 12.9.5 Philips Healthcare Recent Developments
- 12.10 Infervision
- 12.10.1 Infervision Company Information
- 12.10.2 Infervision Business Overview
- 12.10.3 Infervision Revenue in AI-powered Coronary Artery Calcium (CAC) Analysis Software Business (2021-2026)
- 12.10.4 Infervision AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
- 12.10.5 Infervision Recent Developments
- 12.11 Deepwise
- 12.11.1 Deepwise Company Information
- 12.11.2 Deepwise Business Overview
- 12.11.3 Deepwise Revenue in AI-powered Coronary Artery Calcium (CAC) Analysis Software Business (2021-2026)
- 12.11.4 Deepwise AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
- 12.11.5 Deepwise Recent Developments
- 12.12 RSIP Vision
- 12.12.1 RSIP Vision Company Information
- 12.12.2 RSIP Vision Business Overview
- 12.12.3 RSIP Vision Revenue in AI-powered Coronary Artery Calcium (CAC) Analysis Software Business (2021-2026)
- 12.12.4 RSIP Vision AI-powered Coronary Artery Calcium (CAC) Analysis Software Product Portfolio
- 12.12.5 RSIP Vision Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst